DUSA Pharmaceuticals, Inc. (DUSA) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $56.65 --0%
Financial Fact:
Research and development: 1.7M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Research and development: 1.7M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.84 million.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- RBC Capital Downgrades GQG Partners Inc (GQG:AU) to Sector Perform
- Goldman Sachs sees refinery exemptions boosting DK cash flow
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
